DBV Technologies peanut allergy drug fails key study

(Reuters) - Drug developer DBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news